Lars Ekman

(Dr. Lars Ekman M.D., Ph.D.)

Currently holds positions in Sophiris Bio Inc, Prothena Corporation PLC, Amarin Corporation PLC, Spark Therapeutics Inc, Ultragenyx Pharmaceutical Inc and InterMune Inc

Positions
Position Company Period
Chairman of the Board Sophiris Bio Inc Jan. 1, 2014 -
Independent Chairman of the Board Prothena Corporation PLC Dec. 1, 2012 -
Independent Chairman of the Board Amarin Corporation PLC Jan. 1, 2014 -
Independent Director Spark Therapeutics Inc May 1, 2014 -
Independent Director Ultragenyx Pharmaceutical Inc March 17, 2016 -
Lead Independent Director InterMune Inc May 13, 2008 -
Independent Director Ocera Therapeutics Inc July 15, 2013 - June 18, 2015
Executive Chairman of the Board Sophiris Bio Inc Oct. 1, 2012 - Jan. 1, 2014
Lead Independent Non-Executive Director Amarin Corporation PLC Oct. 20, 2011 - Jan. 1, 2014
Executive Chairman of the Board, President Sophiris Bio Inc April 18, 2011 - Aug. 1, 2012
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-01-05 2023-01-03
PS Planned sale
69 -22.1%
60.85
4,198 USD 		69 -22.1% 60.85 4,198 USD
2023-01-05 2023-01-03
PS Planned sale
10 -3.1%
59.46
595 USD 		10 -3.1% 59.46 595 USD
2023-01-05 2023-01-03
PS Planned sale
1,523 -82.5%
58.67
89,353 USD 		1,523 -82.5% 58.67 89,353 USD
2023-01-05 2023-01-03
PS Planned sale
1,303 -41.4%
56.98
74,244 USD 		1,303 -41.4% 56.98 74,244 USD
2023-01-05 2023-01-03
PS Planned sale
6,621 -67.8%
56.33
372,970 USD 		6,621 -67.8% 56.33 372,970 USD
2023-01-05 2023-01-03
PS Planned sale
2,897 -22.9%
55.35
160,341 USD 		2,897 -22.9% 55.35 160,341 USD
2023-01-05 2023-01-03
PS Planned sale
3,411 -21.2%
54.15
184,707 USD 		3,411 -21.2% 54.15 184,707 USD
2022-12-02 2022-12-01
PS Planned sale
6,021 -96.1%
62.12
374,018 USD 		6,021 -96.1% 62.12 374,018 USD
2022-12-02 2022-12-01
PS Planned sale
9,813 -61.0%
61.28
601,388 USD 		9,813 -61.0% 61.28 601,388 USD
2022-11-03 2022-11-01
PS Planned sale
1,661 -87.2%
64.94
107,868 USD 		1,661 -87.2% 64.94 107,868 USD
2022-11-03 2022-11-01
PS Planned sale
3,312 -63.5%
64.26
212,824 USD 		3,312 -63.5% 64.26 212,824 USD
2022-11-03 2022-11-01
PS Planned sale
1,717 -24.8%
62.91
108,013 USD 		1,717 -24.8% 62.91 108,013 USD
2022-11-03 2022-11-01
PS Planned sale
9,143 -56.9%
62.01
566,953 USD 		9,143 -56.9% 62.01 566,953 USD
2022-10-05 2022-10-03
PS Planned sale
1,693 -87.4%
62.96
106,593 USD 		1,693 -87.4% 62.96 106,593 USD
2022-10-05 2022-10-03
PS Planned sale
6,355 -76.6%
62.11
394,677 USD 		6,355 -76.6% 62.11 394,677 USD
2022-10-05 2022-10-03
PS Planned sale
4,277 -34.0%
61.07
261,208 USD 		4,277 -34.0% 61.07 261,208 USD
2022-10-05 2022-10-03
PS Planned sale
3,508 -21.8%
60.32
211,604 USD 		3,508 -21.8% 60.32 211,604 USD
2019-11-07 2019-11-05
PS Planned sale
6,400 -100.0%
18.00
115,230 USD 		6,400 -100.0% 18.00 115,230 USD
2019-09-05 2019-09-03
PS Planned sale
91,016 -100.0%
15.01
1,365,722 USD 		91,016 -100.0% 15.01 1,365,722 USD
2019-03-06 2019-03-04
PS Planned sale
36,700 -100.0%
21.71
796,830 USD 		36,700 -100.0% 21.71 796,830 USD
2019-03-06 2019-03-04
PS Planned sale
98,677 -72.9%
21.16
2,088,074 USD 		98,677 -72.9% 21.16 2,088,074 USD
2019-01-11 2019-01-10
PS Planned sale
7,496 -100.0%
18.62
139,603 USD 		7,496 -100.0% 18.62 139,603 USD
2019-01-11 2019-01-10
PS Planned sale
55,762 -88.2%
18.16
1,012,671 USD 		55,762 -88.2% 18.16 1,012,671 USD
2019-01-11 2019-01-10
PS Planned sale
48,711 -43.5%
17.29
842,140 USD 		48,711 -43.5% 17.29 842,140 USD
2019-01-11 2019-01-10
PS Planned sale
7,247 -6.1%
15.96
115,678 USD 		7,247 -6.1% 15.96 115,678 USD
2019-01-11 2019-01-10
PS Planned sale
21,200 -15.1%
14.92
316,397 USD 		21,200 -15.1% 14.92 316,397 USD